Conditions: Parkinson's Disease
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 1
Healthy volunteers: no

Brief summary:
This is a two-arm, double-blind, placebo-controlled study.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: perampanel intervention 2: placebo
Intervention descriptions: intervention 1: 2 mg/d for 14 days followed by 4 mg/d for 14 days intervention 2: Matching placebo for for 14 days followed by 4 mg/d for 14 days

Protocol document: